
HBV Alliance: Program Overview
Target Audience:
This program is designed to meet the educational needs of community-based healthcare providers at Federally Qualified Health Centers (FQHCs) and community health centers who are involved in the diagnosis and management of patients
with HBV.
Goal:
The HBV Alliance will focus on advancing HBV management and therapeutics knowledge by establishing a platform and forum for health care professionals to experience high-quality education delivered by leading experts in the field.
Educational objectives:
Upon completion of this activity, participants should be able to:
-
Review data on the prevalence and transmission of HBV
-
Define the risk of HBV among different patient populations, highlighting high-risk settings
-
Describe the detrimental effects of untreated, chronic HBV to emphasize the need for diagnosis and treatment
-
Demonstrate strategies to incorporate various diagnostic and treatment guidelines into clinical practice
-
Analyze approved and emerging treatment options for HBV
-
Identify patients that are likely to benefit from emerging treatment options versus currently available therapies

The ECHO model™ breaks down the walls between specialty and primary care. It links expert specialist teams at an academic ‘hub’ with primary care clinicians in local communities — the ‘spokes’ of the model. Essentially, ECHO® creates ongoing learning communities where primary care clinicians receive support and develop the skills they need to treat a particular condition. As a result, they can provide comprehensive, best-practice care to patients with complex health conditions, right where they live.
Accredited by

Provided by
This program is supported by an educational grant from Gilead Sciences.
